India Glycols Board Meeting on Feb 10, 2026 to Approve Q3 FY26 Results
India Glycols board meeting scheduled for February 10, 2026, to approve unaudited financial results for Q3 FY26 and nine months ended December 31, 2025. Trading window remains closed until February 12, 2026.
The announcement is material as it informs stakeholders about the upcoming financial results release date and the period during which trading is restricted. This is crucial information for investors and market participants.
The announcement is a routine disclosure regarding a board meeting to approve financial results and the associated trading window closure. It does not contain any new financial performance data or forward-looking statements that would indicate a positive or negative sentiment.
India Glycols Limited has announced that a meeting of its Board of Directors will be held on Tuesday, 10th February, 2026. The primary agenda for this meeting is to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025.
The company has also provided an update regarding its trading window. As previously intimated on 26th December, 2025, the trading window for dealing in the company's securities, which was closed from Thursday, 1st January, 2026, will continue to remain closed until Thursday, 12th February, 2026, inclusive of both dates.
Further details of the financial results will be hosted on the company's website at www.indiaglycols.com.
What to do with a filing like this
India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.